Brain Therapeutics De-Risking Fund

One generous donor has issued a special 24‑Hour Challenge: If 25 donors make a gift to the Brain Therapeutics De‑Risking Fund today, they will unlock a $25,000 challenge gift to amplify this effort. Your participation—at any level—helps transform high‑potential discoveries into viable brain therapies and sends a powerful signal of collective support for transforming neuroscience research into treatments.

The Picower Institute’s de-risking initiative operates in dedicated lab and office space on Main St. in Cambridge, a short walk from MIT’s Building 46.

About the Brain Therapeutics De‑Risking Fund

Too many breakthrough discoveries in neuroscience never reach patients. The Picower Institute’s Brain Therapeutics De‑Risking Fund is designed to bridge the critical gap between the lab bench and the kitchen table by helping MIT neuroscientists better prepare their most promising ideas for therapies, diagnostics, and technologies for commercialization. By providing early seed funding, expert guidance, and access to MIT’s unparalleled innovation ecosystem, the fund makes investing in discovery less of a risk—overcoming a barrier to progress and accelerating new solutions for brain and nervous system disorders when they are needed most.

De-risking can help basic discoveries become clinically available therapies by ensuring that they undergo the testing and development needed to attract investment.